We’re thrilled to announce that Surge has earned double nominations for the prestigious 10th Global Generics & Biosimilar Awards 2023. Our company is in the running for the coveted titles of “Company of the Year – Asia Pacific” and “Industry Partner of the Year.”
This significant recognition comes as part of the awards ceremony held alongside CPhI Worldwide 2023 in Barcelona. It reflects our ongoing commitment to excellence and innovation in the pharmaceutical industry.
We look forward to the awards ceremony and the opportunity to celebrate our achievements with our industry peers. Stay tuned for updates on this exciting journey!